CAS 1802251-00-8

GSK1379725A 

CAS : 1802251-00-8

Formule : C₂₃H₂₃FN₆O₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 450.4655

Ref: IN-DA01EO3Q

GSK1379725A

CAS : 1802251-00-8

GSK1379725A

Degré de pureté : ≥98%

Masse moléculaire : 450.47g/mol

Ref: 54-BUP15250

GSK1379725A

CAS : 1802251-00-8

GSK1379725A is a selective BPTF ligand (Kd = 2.8 μM).

Formule : C₂₃H₂₃FN₆O₃

Degré de pureté : 99.51%

Couleur et forme : Solid

Masse moléculaire : 450.47

Ref: TM-T15424

GSK 1379725A

CAS : 1802251-00-8

GSK 1379725A is a new drug that has been shown to be effective in the treatment of cancer and inflammatory bowel disease. GSK 1379725A targets the ubiquitin ligases that play a role in protein degradation, leading to the activation of creatine kinase. This enzyme is important for energy production and cellular function. The drug also inhibits inflammation by inhibiting the mineralocorticoid receptor, which is involved in immune system regulation. GSK 1379725A works by generating electrons from oxidation catalysts and transferring them to molecular oxygen through an electron transfer chain reaction. This process leads to the generation of reactive oxygen species (ROS) that can cause oxidative stress and damage DNA, proteins, and lipids.

Formule : C₂₃H₂₃FN₆O₃

Degré de pureté : Min. 95%

Masse moléculaire : 450.47 g/mol

Ref: 3D-CXC25100